Publications by authors named "Isabelle Cadron"

Claim this Profile
P
Preoperative tumour size assessment in patients with early-stage cervical cancer: Final results of the SENTIX study.
Martina Borčinová, Christhardt Köhler, Kristýna Němejcová, Ignacio Zapardiel, Jaroslav Klát, Isabelle Cadron

Gynecol Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome and clinical management of 275 patients with advanced ovarian cancer International Federation of Obstetrics and Gynecology II to IV inside the European Ovarian Cancer Translational Research Consortium-OVCAD.
Radoslav Chekerov, Ioana Braicu, Dan Cacsire Castillo-Tong, Rolf Richter, Isabelle Cadron

Int J Gynecol Cancer· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma concentrations of the vitamin E-binding protein afamin are associated with overall and progression-free survival and platinum sensitivity in serous ovarian cancer--a study by the OVCAD consortium.
Andreas Melmer, Linda Fineder, Claudia Lamina, Barbara Kollerits, Benjamin Dieplinger, Isabelle Cadron

Gynecol Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "Leuven" paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study.
Isabelle Cadron, Leyla Abdulkadir, Evelyn Despierre, Patrick Berteloot, Patrick Neven

Gynecol Oncol· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive models for long term survival after premature rupture of membranes.
Lieveke Ameye, Jos De Brabanter, Johan K Suykens, Isabelle Cadron, Roland Devlieger

Conf Proc IEEE Eng Med Biol Soc· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses.
Toon Van Gorp, Joan Veldman, Ben Van Calster, Isabelle Cadron, Karin Leunen

Eur J Cancer· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validating the impact of a molecular subtype in ovarian cancer on outcomes: a study of the OVCAD Consortium.
Dietmar Pils, Gudrun Hager, Dan Tong, Stefanie Aust, Georg Heinze, Isabelle Cadron

Cancer Sci· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer.
Sofie Torfs, Isabelle Cadron, Frederic Amant, Karin Leunen, Patrick Berteloot

Eur J Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic aberrations relate early and advanced stage ovarian cancer.
Afra Zaal, Wouter J Peyrot, P M J J Berns, Maria E L van der Burg, Jan H W Veerbeek, Isabelle Cadron

Cell Oncol (Dordr)· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS.
Toon Van Gorp, Isabelle Cadron, Anneleen Daemen, Bart De Moor, Etienne Waelkens

Proteome Sci· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages IIA-IV: analysis of the OVCAD data.
Stephan Polterauer, Ignace Vergote, Nicole Concin, Ioana Braicu, Radoslav Chekerov, Isabelle Cadron

Int J Gynecol Cancer· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gynecologic oncology training systems in Europe: a report from the European network of young gynaecological oncologists.
Murat Gultekin, Polat Dursun, Boris Vranes, Rene Laky, Michaela Bossart, Isabelle Cadron

Int J Gynecol Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis of laser microdissected ovarian cancer tissue with SELDI-TOF MS.
Isabelle Cadron, Toon Van Gorp, Philippe Moerman, Etienne Waelkens, Ignace Vergote

Methods Mol Biol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The utility of proteomics in gynecologic cancers.
Toon Van Gorp, Isabelle Cadron, Ignace Vergote

Curr Opin Obstet Gynecol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: an analysis of 163 patients.
Dimitris Tsolakidis, Frederic Amant, Karin Leunen, Isabelle Cadron, Patrick Neven

Eur J Cancer· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells.
Isabelle Cadron, Toon Van Gorp, Attila Mihalyi, Catherina Luyten, Katrien Drijkoningen

Gynecol Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of proteomics in ovarian cancer: which sample should be used?
Isabelle Cadron, Toon Van Gorp, Dirk Timmerman, Frederic Amant, Etienne Waelkens

Gynecol Oncol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does paclitaxel-carboplatin chemotherapy in a dose-dense regimen enhance survival of BRCA-related ovarian cancer patients?
Karin Leunen, Isabelle Cadron, Toon Van Gorp, Frédéric Amant, Patrick Berteloot

Int J Gynecol Cancer· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles.
Isabelle Cadron, Toon Van Gorp, Frederic Amant, Ignace Vergote, Philippe Moerman

Anticancer Res· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: first report on the technique used in 5 patients.
Ignace Vergote, Bram Pouseele, Toon Van Gorp, Bernard Vanacker, Karin Leunen, Isabelle Cadron

Acta Obstet Gynecol Scand· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal chemotherapy in patients with advanced ovarian cancer: the con view.
Ignace Vergote, Frederic Amant, Karin Leunen, Isabelle Cadron, Toon Van Gorp

Oncologist· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy for recurrent cervical cancer.
Isabelle Cadron, Toon Van Gorp, Frederic Amant, Karin Leunen, Patrick Neven

Gynecol Oncol· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The "Leuven" dose-dense paclitaxel/carboplatin regimen in patients with recurrent ovarian cancer.
Isabelle Cadron, Karin Leunen, Frédéric Amant, Toon Van Gorp, Patrick Neven

Gynecol Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of borderline ovarian neoplasms.
Isabelle Cadron, Karin Leunen, Toon Van Gorp, Frederic Amant, Patrick Neven

J Clin Oncol· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The management of borderline tumours of the ovary.
Isabelle Cadron, Frederic Amant, Toon Van Gorp, Patrick Neven, Karin Leunen

Curr Opin Oncol· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis